ESCC and esophageal adenocarcinoma are distinct diseases with different etiologies. ESCC remains the more common type of esophageal carcinoma in economically developing countries as well as globally. Approximately half of the world's 500,000 new ESCC cases each year occur in China, where the disease is a major public health problem. Three GWAS have examined ESCC 1-3 , and 2 subsequent analyses used combinations of the three studies 4,5 to report as many as 12 loci associated with ESCC risk. Four additional loci have been reported on the basis of an interaction with alcohol consumption, a known risk factor for ESCC 4 . Two of the GWAS 1,2 drew subjects primarily from the Taihang Mountain region of Henan and Shanxi provinces where ESCC occurs at very high rates. Total mortality due to ESCC and gastric cardia cancer can exceed 20% in the communities at highest risk in this region 6 . The third GWAS 3 drew subjects from a range of locations in China, including a substantial collection from Beijing, where the population comprises individuals who originate from all provinces in China. The contribution of lifestyle risk factors to ESCC differs widely between locations in China, with alcohol consumption being a notable example. Heavy consumption of alcoholic beverages is a known cause of ESCC 7 but historically has been uncommon in the high-incidence regions for ESCC in China 8 . Therefore, consumption of alcoholic beverages had little contribution to the extraordinarily high rates of ESCC, leaving the high incidence largely unexplained. To discover additional ESCC susceptibility alleles, we conducted a joint analysis of the three original GWAS and followed up promising association signals in an independent set of new cases and controls.
ESCC and esophageal adenocarcinoma are distinct diseases with different etiologies. ESCC remains the more common type of esophageal carcinoma in economically developing countries as well as globally. Approximately half of the world's 500,000 new ESCC cases each year occur in China, where the disease is a major public health problem. Three GWAS have examined ESCC [1] [2] [3] , and 2 subsequent analyses used combinations of the three studies 4, 5 to report as many as 12 loci associated with ESCC risk. Four additional loci have been reported on the basis of an interaction with alcohol consumption, a known risk factor for ESCC 4 . Two of the GWAS 1,2 drew subjects primarily from the Taihang Mountain region of Henan and Shanxi provinces where ESCC occurs at very high rates. Total mortality due to ESCC and gastric cardia cancer can exceed 20% in the communities at highest risk in this region 6 . The third GWAS 3 drew subjects from a range of locations in China, including a substantial collection from Beijing, where the population comprises individuals who originate from all provinces in China. The contribution of lifestyle risk factors to ESCC differs widely between locations in China, with alcohol consumption being a notable example. Heavy consumption of alcoholic beverages is a known cause of ESCC 7 but historically has been uncommon in the high-incidence regions for ESCC in China 8 . Therefore, consumption of alcoholic beverages had little contribution to the extraordinarily high rates of ESCC, leaving the high incidence largely unexplained. To discover additional ESCC susceptibility alleles, we conducted a joint analysis of the three original GWAS and followed up promising association signals in an independent set of new cases and controls.
The subjects from the three underlying GWAS, which include additional subjects who were scanned after the first round of publications plus the additional subjects used for replication of the top association signals, are described in Supplementary Table 1. In our joint analysis, we investigated the individual GWAS data drawn from 3 studies in China, which consisted of 5,337 ESCC cases and 5,787 controls of Han Chinese ancestry. The National Cancer Institute (NCI) GWAS used the Illumina 660W-Quad SNP microarray, the Henan GWAS used the Illumina 610-Quad SNP microarray and the Beijing GWAS used the Affymetrix GeneChip Human Mapping 6.0 set. Eigenvector plots from a principal-components analysis (PCA) of 25,676 uncorrelated genotyped SNPs (r 2 < 0.01 in our combined control set) are shown in Supplementary Figure 1 . The results show distinct clusters of individuals corresponding to different source populations. However, only the first two eigenvectors were significant (P < 0.05) in the base cancer risk model and were thus used to adjust for population stratification in the final estimates for our joint analysis. To explore the contributions of untyped common variants, we assessed these through the imputation of 40.5 million variants, using version 3 of the 1000 Genomes Project data as the reference for each of the three data sets before combining them as described in the Online Methods and Supplementary Table 2. After filtering out SNPs with minor allele frequency (MAF) of <1% or imputation information criteria (INFO) of <0.3, we advanced 7,556,215 SNPs to the association analysis. The inflation factor λ for the joint analysis was 1.01 for all SNPs, which indicates that population stratification should not be a concern. A quantile-quantile plot for the joint casecontrol comparison with all SNPs and after the exclusion of SNPs within 500 kb of loci previously reported to be associated with ESCC is provided in Supplementary Figure 2 . Individual quantile-quantile plots for each of the three underlying GWAS data sets are provided in Supplementary Figures 3-5 . Fourteen promising SNPs identified on the basis of the joint analysis (Online Methods) were genotyped in an additional 9,654 ESCC cases and 10,058 controls divided between subjects from Henan province and Beijing. 1 0 0 2 VOLUME 46 | NUMBER 9 | SEPTEMBER 2014 Nature GeNetics l e t t e r s
The joint analysis identified two new genome-wide significant loci at 5q31.2 ( Fig. 1a) and 17p13.1 (Fig. 1b) associated with risk of ESCC in the pooled data of individual genotypes for all three GWAS and two replication studies ( Table 1 and Supplementary Table 3 ). At 5q31.2, rs7447927, a synonymous SNP located in TMEM173 (encoding transmembrane protein 173), had a combined per-allele OR (95% CI) of 0.85 (0.82-0.88); P = 7.72 × 10 −20 . At 17p13.1, rs1642764, an intronic SNP located in ATP1B2 (encoding ATPase, Na + /K + -transporting, β2 polypeptide), which was just telomeric to the tumor-suppressor gene TP53, had a combined per-allele OR (95% CI) of 0.88 (0.85-0.91); P = 3.10 × 10 −13 . No statistically significant heterogeneity was observed across the three pooled GWAS and two replication studies for either locus ( Table 1) . Furthermore, the associations were confirmed independently in the follow-up sets collected from both high-and low-risk populations.
On further analysis, we observed an additional susceptibility locus that showed geographic differences in effect, such that significant association was observed only in the two GWAS 1,2 that included subjects from populations at the highest risk for ESCC. In joint analyses using all three GWAS, a SNP at 6p21.32 showed a nearly genome-wide significant association; however, statistically significant heterogeneity among studies (P = 0.015) was evident when subjects from the Beijing GWAS and replication subjects were included (among the three pooled GWAS and two replication studies, as shown in Table 1 ). The test for heterogeneity became non-significant when the Beijing GWAS and Beijing replication subjects were excluded ( Table 1) . When the analyses were restricted to subjects from high-incidence regions, rs35597309, located in the human leukocyte antigen (HLA) class II gene region between HLA-DRB1 and HLA-DQA1, also had a per-allele OR (95% CI) of 1.33 (1.22-1.46); P = 1.99 × 10 −10 ( Table 1 and Supplementary Fig. 6 ). This heterogeneity between high-and low-risk regions was also evident when data from the three separate GWAS were examined (Supplementary Table 4 ). Further genotyping and, possibly, sequencing are necessary to map the susceptibility alleles across the HLA class II region owing to its complex structure defined by long-range haplotypes.
Finally, our joint analysis identified a promising association with rs61271866 (P = 5.18 × 10 −8 ), an intergenic SNP at 9p21.3 that overlaps the CDKN2B-CDKN2A gene cluster (encoding cyclin-dependent kinase inhibitors 2B and 2A) (Supplementary Table 3 ). Variants in this region have been associated with risk of melanoma 9 , childhood acute lymphoblastic leukemia 10 , chronic lymphocytic leukemia 11 and glioma 12 , as well as with ESCC 13 in a previous study using a subset of the samples examined here. This SNP showed heterogeneity in effect among individual studies in the GWAS (Supplementary Table 4 ) and between the joint stage 1 and replication-phase results (Supplementary Table 3 ). The heterogeneity profile for the 9p21.3 locus was more varied in comparison to the HLA class II locus at 6p21.32, indicating that validation of this finding will require additional work.
We tested for interactions of the four associated SNPs identified (rs7447927, rs1642764, rs35597309 and rs61271866) with use of alcohol (Supplementary Table 5 ) or tobacco (Supplementary Table 6 ). Because of substantial differences in the degree of alcohol and tobacco . LD structure based on 1000 Genomes Project CHB data (n = 91) was visualized with snp.plotter software. The line graph shows the likelihood-ratio statistics (y axis, right) for recombination hotspots as determined by SequenceLDhot software on the basis of the background recombination rates inferred by PHASE v2.1 using 1000 Genomes Project CHB data. Physical locations are based on NCBI human genome Build 37. Gene annotation was based on the NCBI RefSeq genes from the UCSC Genome Browser.
npg l e t t e r s use among the populations, we conducted these tests separately for each of the three underlying studies. In total, this analysis comprised 24 tests, and we found 1 SNP that had a nominally significant interaction with tobacco use (rs35597309 in the NCI GWAS; Supplementary Table 6 ), but the difference did not replicate in the 2 other studies and is thus most likely due to chance. We further note that the number of GWAS subjects with these covariate data from Henan was limited.
Here we report a new finding of an association between rs7447927, a synonymous SNP in TMEM173, and ESCC risk. TMEM173 (also known as STING) facilitates innate immune reactions to viruses and bacteria through the production of type I interferon 14 . The only previous GWAS signal at this locus (rs13181561) was demonstrated to be associated with the modulation of interferon-α responses to the smallpox vaccine 15 and is highly correlated with rs7447927 (r 2 = 0.956 in 1000 Genomes Project data for the CHB (Han Chinese in Beijing, China) population). rs13181561 is also tagged as an expression quantitative trait locus in lymphoblastoid cells (Supplementary Table 7 ) that alters the expression of genes in segment AC135457.2. This genomic region includes SLC23A1 (encoding the sodium-dependent vitamin C transporter), which is critical for vitamin C transport 16 . Interestingly, low vitamin C levels have been implicated in risk of ESCC 17 .
The new susceptibility locus at 17p13.1 is marked by rs1642764, an intronic SNP located within the ATP1B2 gene; this variant resides in a linkage disequilibrium (LD) block that includes the 3′ region of TP53 (Fig. 1b) . Alteration of TP53 regulation or function could be a plausible explanation for the observed association between rs1642764 and risk of ESCC. It is noteworthy that no previous GWAS for cancer has reported a conclusive association with a variant in or around TP53. Recently, a candidate gene study of genotyped and imputed SNPs across TP53 reported a strong association of a SNP with a low MAF, rs78378222, with glioma risk (P = 6.86 × 10 −24 with MAF = 0.013 in a population of European ancestry) 18 . We also observed that TP53 was frequently inactivated in ESCC 19 . Our target SNP in this region was in LD with several other SNPs, notably, rs1050541 (r 2 = 0.575), which alters a binding site for RAD21 (Supplementary Table 7) . RAD21 is a key component of the cohesion complex, which binds to DNA and is essential for mitosis, homologous DNA repair and enhancer activities and might be relevant to cancer 20 . Alternatively, this SNP falls between recombination hotspots that include the SHBG gene, and variants bracketing this SNP are known to be associated with sex hormone-binding globulin regulation and serum testosterone concentration 21 . Esophageal cancer occurs predominantly in males in low-incidence populations, but this incidence pattern has typically been attributed to greater tobacco smoking and alcohol consumption by men in comparison to women. Recent studies have suggested that hormonal factors might have a role in the development of ESCC 22, 23 .
In published GWAS, HLA class II genetic variants in close proximity (<20 kb) to rs35597309 at 6p21.32 have been associated with multiple cancers, including nasopharyngeal carcinoma 24 , hepatocellular carcinoma 25 , lung cancer in never-smokers 26 and familial chronic lymphocytic leukemia 27 , as well as with autoimmune diseases, including Crohn's disease 28 and lupus 29 . This SNP resides between HLA-DRB1 and HLA-DQA1, both of which are major histocompatibility complex (MHC) class 2 genes that function in antigen presentation. The HLA region is large and complex, showing unusually long-range LD that makes the interpretation of GWAS signals in this region difficult. rs35597309 was in perfect LD (r 2 = 1.0) with 34 other SNPs within 2 Mb of it (Supplementary Table 7) , including with 2 missense mutations in HLA-DQA1 and a host of putative protein-binding sites, enhancers and regulatory motifs. But the LD with the top association signals in this region from previously reported studies of cancer was low: r 2 < 0.1 for rs2860580 (nasopharyngeal carcinoma), rs9272105 (hepatocellular carcinoma), rs2395185 (lung cancer) and rs674313 One of the new loci showed significant heterogeneity (P = 0.015) among the three studies, and the associations are also reported using only the two GWAS and one replication set that primarily included subjects from populations with high incidence in the Taihang Mountains of north-central China. VOLUME 46 | NUMBER 9 | SEPTEMBER 2014 Nature GeNetics l e t t e r s (chronic lymphocytic leukemia) in 1000 Genomes Project data for the combined CHB and JPT (Japanese in Tokyo, Japan) populations. Our results provide evidence for an association between variants at 6p21.32 and risk of ESCC, although the association was restricted to the studies that examined subjects from the high-incidence Taihang Mountain region. Although it is plausible that our results could be due to a gene-environment interaction between HLA genotypes and an uncharacterized risk factor specific to the Taihang Mountains, it is also possible that chance could account for this finding. The result was, however, confirmed in the Henan replication set (P = 0.001). We know that populations in this region suffer from very high rates of ESCC, which is likely multifactorial and could involve immune challenges. It is also important to note that the Han Chinese population is genetically diverse, and this difference in association might be due to true differences in the genomic structure of the HLA region between subjects from the Taihang Mountains and other parts of China. But we note that the allele frequency was similar for the Henan and Beijing replication sets ( Table 1) . Future work should use genomic methods specifically designed to investigate the HLA region to explore these results. We also note that a region at 6p22.1 that is linked to other HLA alleles has been associated with risk of Barrett's esophagus, the precursor lesion for esophageal adenocarcinoma 30 .
Individual GWAS and joint analysis results for the 12 maineffect GWAS loci reported in 5 previous publications [1] [2] [3] [4] [5] are shown in Supplementary Table 8 . Joint analysis of the pooled data from the three GWAS did not strengthen the evidence for all previously reported loci. We observed strong associations for SNPs in loci harboring PLCE1, CASP8, RUNX1 and CHEK2 but no signal for four loci. The Beijing GWAS showed geographic differences in association for some SNPs 3 , and this variation might be attributed, in part, to differences in environmental exposures and habits, such as alcohol consumption. A previous analysis by Wu et al. 4 using partial data from two of the studies also showed substantial heterogeneity between GWAS. Of the 18 signals identified in analyses of both main effects and alcohol interaction in the Beijing data, only 4 replicated in subjects from the Shanxi Upper Gastrointestinal Cancer Genetics Study 1 .
In conclusion, we present the joint analysis of the individual genotype data from three previously published GWAS in China and have established two new loci associated with risk of ESCC across all three studies and two promising signals, the most notable, in the HLA class II region. The latter appears to be present only in subjects from the high-incidence Taihang Mountain region of China. Environmental factors have previously been shown to be of varied relevance for ESCC in different Chinese populations, and this variation might have led to differential GWAS findings. Here we find additional evidence for distinct results among these populations. Etiologic heterogeneity might have an important role in interpreting GWAS results and should be considered when GWAS are extended to understudied populations with distinct lifestyles. Lastly, further work is needed to fine-map the regions in order to identify the optimal alleles for laboratory studies that will provide an understanding of the basic biology underlying the ESCC susceptibility alleles and their interaction with environmental factors. 
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